Long-term outcome after infliximab for refractory ulcerative colitis-Reference-Cited by-同舟云学术

Long-term outcome after infliximab for refractory ulcerative colitis

Published:2008-09 Issue:3 Volume:2 Page:219-225
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

Ferrante Marc,Vermeire Séverine,Fidder Herma,Schnitzler Fabian,Noman Maja,Van Assche Gert,De Hertogh Gert,Hoffman Ilse,D'Hoore Andre,Van Steen Kristel,Geboes Karel,Penninckx Freddy,Rutgeerts Paul

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/2/3/219/7799234/2-3-219.pdf

Reference14 articles.

1. Medical therapy for ulcerative colitis 2004;Hanauer;Gastroenterology,2004

2. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

3. Predictors of early response to infliximab in patients with ulcerative colitis;Ferrante;Inflamm Bowel Dis,2007

4. A genetic panel strongly predicts the need for colectomy in ulcerative colitis;Mcgovern;Gastroenterology,2004

5. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology;Silverberg;Can J Gastroenterol,2005

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

2. CT-based pancreatic radiomics predicts secondary loss of response to infliximab in biologically naïve patients with Crohn’s disease;Insights into Imaging;2024-03-13

3. Recent Trends in Non-Invasive Methods of Diagnosis and Evaluation of Inflammatory Bowel Disease: A Short Review;International Journal of Molecular Sciences;2024-02-08

4. Predictors of non-response to ongoing conservative therapy in patients with inflammatory bowel disease;Miscellaneous Considerations in Inflammatory Bowel Disease;2024-01-09

5. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry;Therapeutic Advances in Gastroenterology;2024-01